Hunan Fangsheng Pharmaceutical Co., Ltd. (SHA:603998)

SHA:603998 Revenue

Hunan Fangsheng Pharmaceutical had revenue of 494.97M CNY in the quarter ending June 30, 2026, with 18.94% growth. This brings the company's total for the last twelve months to 1.87B, up 9.90% year-over-year. In the year 2025, Hunan Fangsheng Pharmaceutical had annual revenue of 1.75B, down -1.75%. That makes Hunan Fangsheng Pharmaceutical the 14,986th largest company in the world by revenue and 2,684th in China.

• Revenue (ttm): 1.87B
• Revenue Growth: +9.90%
• P/S Ratio: 2.42
• Revenue / Employee: 1.00M
• Employees: 1,868
• Market Cap: 4.53B

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Pharmaceutical Manufacturing Business 1.65B 94.9%
• Other 88.41M 5.1%

Fiscal year ended Dec 31, 2025 See the full SHA:603998 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.75B	-31.05M	-1.75%
Dec 31, 2024	1.78B	148.95M	9.15%
Dec 31, 2023	1.63B	-163.46M	-9.12%
Dec 31, 2022	1.79B	225.03M	14.36%
Dec 31, 2021	1.57B	288.21M	22.54%

Data Source: S&P Global Market Intelligence Last updated: Aug 28, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 19, 2026

Data Sources Report a data error